Suppr超能文献

接受主动监测的小肾肿瘤患者的条件生存。

Conditional survival of patients with small renal masses undergoing active surveillance.

机构信息

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

BJU Int. 2019 Mar;123(3):447-455. doi: 10.1111/bju.14486. Epub 2018 Aug 27.

Abstract

OBJECTIVES

To determine conditional survival for patients with small renal masses (SRMs) undergoing active surveillance (AS).

MATERIALS AND METHODS

Patients were enrolled in a prospective AS protocol at our institution between May 2005 and January 2016. Patients with SRMs ≤4 cm with serial cross-sectional imaging available in-house for review were included. Overall survival (OS) was estimated using the Kaplan-Meier method and modelled via Cox proportional hazards models. The primary endpoints analysed were the conditional probability of survival and tumour growth over time. Landmark analysis was used to evaluate survival outcomes beyond the 2-year mark after the initial scan. The relative conditional survival of patients on AS was compared to those undergoing partial nephrectomy (PN) using inverse probability of treatment weighting.

RESULTS

A total of 272 patients were included in this analysis. The mean initial SRM size was 1.74 ± 0.77 cm, and the mean mass size closest to the 2-year mark was 1.97 ± 0.83 cm. The likelihood of continued survival to 5 years improved after the 2-year landmark. Patients with masses <3 cm who survived the first 2 years on AS had a 0.84-0.85 chance of surviving to 5 years, and if they survived 3 years, the probability of surviving to 5 years improved to 0.91. A slow tumour growth (β: 0.12; P < 0.001) with parallel growth rates was found for tumours <3 cm. Patients on AS and those who underwent PN had similar OS for ~7 years, beyond which PN demonstrated a trend of lower risk of death compared with AS (hazard ratio 0.57; P = 0.07).

CONCLUSIONS

The conditional survival probability of patients with SRMs <3 cm on AS increased after 2 years. This information may prove useful to urologists and patients who are considering continuing AS vs intervention after the first 2 years on AS.

摘要

目的

确定接受主动监测(AS)的小肾肿瘤(SRM)患者的条件生存情况。

材料和方法

患者于 2005 年 5 月至 2016 年 1 月在我院参与前瞻性 AS 方案。纳入标准为肿瘤最大径≤4cm,且有可供回顾的连续横断面成像。采用 Kaplan-Meier 方法估计总生存(OS),并用 Cox 比例风险模型进行建模。主要分析终点为随时间推移的生存概率和肿瘤生长的条件概率。使用 landmark 分析评估初始扫描后 2 年以上的生存结局。使用逆概率治疗加权法比较 AS 患者与接受部分肾切除术(PN)患者的相对条件生存情况。

结果

本分析共纳入 272 例患者。初始 SRM 平均大小为 1.74 ± 0.77cm,最接近 2 年标记的平均肿瘤大小为 1.97 ± 0.83cm。在 2 年 landmark 后,继续生存至 5 年的可能性提高。在 AS 上生存超过前 2 年的<3cm 肿块患者,生存至 5 年的概率为 0.84-0.85,若生存 3 年,生存至 5 年的概率提高至 0.91。<3cm 的肿瘤呈缓慢生长(β:0.12;P<0.001),且生长率平行。AS 组和 PN 组患者的 OS 相似,超过 7 年时,PN 组死亡风险较 AS 组呈下降趋势(风险比 0.57;P=0.07)。

结论

在接受 AS 的<3cm SRM 患者中,2 年后条件生存概率增加。这一信息可能有助于泌尿科医生和患者在 AS 治疗 2 年后决定继续 AS 还是进行干预。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验